I don't disagree with your opinion. But, I find it ironic that when Joe embarked on this spin-off scheme to unlock the real value of NGIO there was no COVID. So now NGIO has created a COVID vaccine and a potential revenue stream where there was none ... and should add value. But it seems everything hinges on this bonus opportunity ...
(2)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links